Does CABOZANTINIB S-MALATE Cause Therapy change? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Therapy change have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.1% of all adverse event reports for CABOZANTINIB S-MALATE.
20
Reports of Therapy change with CABOZANTINIB S-MALATE
0.1%
of all CABOZANTINIB S-MALATE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Therapy change From CABOZANTINIB S-MALATE?
Of the 20 reports, 1 (5.0%) resulted in death.
Is Therapy change Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Therapy change?
MACITENTAN (346)
SELEXIPAG (285)
EPOPROSTENOL (237)
LENALIDOMIDE (212)
PALBOCICLIB (204)
CAPECITABINE (200)
TREPROSTINIL (189)
GLATIRAMER (184)
AMBRISENTAN (143)
ADALIMUMAB (139)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Therapy change Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE